Differential proteomic profile of leukemic CD34+ progenitor cells from chronic myeloid leukemia patients

Oncotarget
Maria Rosaria RicciardiAgostino Tafuri

Abstract

Chronic Myeloid Leukemia (CML) is a stem cell disease sustained by a rare population of quiescent cells which are to some extent resistant to tyrosine kinase inhibitors (TKIs). BCR-ABL oncogene activates multiple cross-talking signal transduction pathways (STP), such as RAS/MEK/ERK, PI3K/Akt, Wnt and STAT5, contributing to abnormal proliferation of clonal cells. From this perspective, the aim of this study was to analyze the expression and activation profile of STP involved in the mechanisms of cell proliferation/quiescence and survival of the progenitor CD34+ cells from chronic phase (CP) CML. Our results showed that CP-CML CD34+ progenitors were characterized by significant lower phosphorylation of proteins involved in the regulation of growth and cell survival, such as tyrosine kinases of the Src family and members of STAT family, and by a significant higher phosphorylation of p53 (Ser15), compared to normal CD34+ cells from healthy donors. Consistent with these results, cell cycle analysis demonstrated that CP-CML CD34+ cells were characterized by higher percentage of cells in G0-phase compared to normal CD34+ cells. Analysis of expression profile on proteins involved in the apoptotic machinery revealed that, in addition, C...Continue Reading

References

Apr 5, 2001·The New England Journal of Medicine·B J DrukerC L Sawyers
Feb 8, 2003·The Lancet Oncology·Carlo B Gambacorti-PasseriniLeonardo Scapozza
Apr 4, 2008·Nature Reviews. Cancer·Michael Savona, Moshe Talpaz
Jan 19, 2011·Molecular and Cellular Biochemistry·Xingchen PengAiping Tong
Oct 11, 2011·Blood Reviews·Sameek Roychowdhury, Moshe Talpaz
Dec 8, 2011·International Journal of Laboratory Hematology·J ZhangX Liu
Jun 19, 2012·Cell Stem Cell·Jane E Visvader, Geoffrey J Lindeman
Jul 25, 2012·Nature Reviews. Cancer·Thomas O'HareMichael W Deininger
Mar 23, 2013·British Journal of Pharmacology·A SinclairT L Holyoake
Jan 11, 2014·Critical Reviews in Oncology/hematology·Massimo BrecciaGiuseppe Saglio
Jun 10, 2016·Nature·Sheela A AbrahamTessa L Holyoake
Feb 6, 2017·Blood·Tessa L Holyoake, David Vetrie
Feb 9, 2017·Nature Reviews. Clinical Oncology·Timothy P Hughes, David M Ross
Mar 9, 2017·The New England Journal of Medicine·Andreas HochhausUNKNOWN IRIS Investigators

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
Protein Array
electrophoresis
leukapheresis

Software Mentioned

Excel
ModFit LT
Mat
ImageJ

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.